#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13568	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2228	606.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1551	1551	C	775	C	729	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13568	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2228	606.3	0	HET	.	.	.	C207T	.	207	207	C	574	574	C	718	C,T	543,144	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25264	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3630	694.2	0	.	n	.	0	T695C	SNP	695	695	T	1075	1075	C	732	C	685	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25264	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3630	694.2	0	.	n	.	0	A1638G	SNP	1638	1638	A	2018	2018	G	814	G,A	769,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25264	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3630	694.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2351	2351	C	836	C	786	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25264	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3630	694.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2425	2425	A	830	A	794	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25264	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3630	694.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2977	2977	C	786	C	745	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25264	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3630	694.2	0	HET	.	.	.	G2680A	.	2680	2680	G	3060	3060	G	778	G,A	582,166	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	1922	folP	852	852	99.77	folP.l6.c30.ctg.1	1708	111.7	0	.	p	.	0	A204V	NONSYN	610	612	GCA	939	941	GTA	208;209;211	G;T,C;A,G	203;201,1;202,1	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	1922	folP	852	852	99.77	folP.l6.c30.ctg.1	1708	111.7	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGC	1011	1013	AGC	199;199;199	A;G;C	190;190;187	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5314	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3391	156.2	1	SNP	p	S91F	1	.	.	271	273	TTC	597	599	TTC	189;188;190	T;T;C	176;177;181	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5314	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3391	156.2	1	SNP	p	G95N	0	.	.	283	285	GGC	609	611	GGC	183;183;181	G;G;C	174;174;171	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5314	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3391	156.2	1	SNP	p	D95G	1	.	.	283	285	GGC	609	611	GGC	183;183;181	G;G;C	174;174;171	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1590	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1318	119.9	1	SNP	p	G45D	0	.	.	133	135	GGC	427	429	GGC	221;221;225	G;G;C	198;199;206	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	874	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	902	95.9	0	.	n	.	0	A197.	DEL	197	197	A	548	548	A	208	A	188	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4722	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3120	150.8	1	SNP	p	D86N	0	.	.	256	258	GAC	632	634	GAC	185;185;187	G;A;C	175;173;179	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4722	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3120	150.8	1	SNP	p	S87R	1	.	.	259	261	CGT	635	637	CGT	187;186;185	C;G;T	179;178;174	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4722	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3120	150.8	1	SNP	p	R87I	0	.	.	259	261	CGT	635	637	CGT	187;186;185	C;G;T	179;178;174	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4722	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3120	150.8	1	SNP	p	R87W	0	.	.	259	261	CGT	635	637	CGT	187;186;185	C;G;T	179;178;174	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4722	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3120	150.8	1	SNP	p	S88P	0	.	.	262	264	TCC	638	640	TCC	187;188;187	T;C;C	178;180;180	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4244	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2645	159.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1505	1507	GGC	198;196;195	G;G;C	182;181;174	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3824	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2341	162.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1229	1231	GCC	224;226;225	G;C;C	205;207;204	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3824	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2341	162.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1232	1234	ATG	224;224;226	A;T;G	206;206;205	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3824	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2341	162.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1244	1246	ACC	227;228;227	A;C;C	210;210;209	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3824	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2341	162.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1244	1246	ACC	227;228;227	A;C;C	210;210;209	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3824	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2341	162.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1745	1747	ACC	207;206;207	A;C;C	185;189;191	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3824	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2341	162.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1799	1801	GCG	197;199;201	G;C,T;G	186;185,1;192	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3824	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2341	162.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1799	1801	GCG	197;199;201	G;C,T;G	186;185,1;192	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3824	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2341	162.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1922	1924	GGT	140;140;142	G,T;G;T	126,1;126;124	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3824	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2341	162.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1931	1933	AGC	145;144;145	A;G;C	128;128;127	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3824	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2341	162.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1949	1951	CCG	126;129;131	C,G;C,G;G,T	96,8;100,1;104,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5382	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3104	172.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1643	1645	CCG	203;204;201	C;C;G	173;186;176	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2078	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1897	108.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	565	565	C	135	C	126	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	246	porB1a	984	188	90.1	porB1a.l15.c30.ctg.1	1101	18.6	0	.	p	.	0	H217N	NONSYN	649	651	CAT	928	930	AAT	13;13;13	A;A;T	13;13;13	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	246	porB1a	984	188	90.1	porB1a.l15.c30.ctg.1	1101	18.6	0	.	p	.	0	D218N	NONSYN	652	654	GAT	931	933	AAT	13;13;13	A;A;T	13;13;13	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	246	porB1a	984	188	90.1	porB1a.l15.c30.ctg.1	1101	18.6	0	.	p	.	0	V226A	NONSYN	676	678	GTA	955	957	GCA	8;8;8	G;C;A	8;8;8	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	246	porB1a	984	188	90.1	porB1a.l15.c30.ctg.1	1101	18.6	0	.	p	.	0	.	MULTIPLE	700	702	ACT	978	980	GTA	5;6;6	G;T;A	5;6;6	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	246	porB1a	984	188	90.1	porB1a.l15.c30.ctg.1	1101	18.6	0	.	p	.	0	N237fs	FSHIFT	709	709	A	987	987	A	6	A	6	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2572	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1589	160.6	1	SNP	p	G120K	1	.	.	358	360	AAG	658	660	AAG	222;226;228	A;A;G	204;208;205	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2572	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1589	160.6	1	SNP	p	A121N	1	.	.	361	363	AAC	661	663	AAC	227;228;230	A;A;C	209;209;207	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2572	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1589	160.6	1	SNP	p	N121D	0	.	.	361	363	AAC	661	663	AAC	227;228;230	A;A;C	209;209;207	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9726	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4996	194.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1082	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1009	106.0	1	SNP	p	V57M	1	.	.	169	171	ATG	536	538	ATG	217;216;217	A;T;G	207;207;208	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
